TransMedics Group, Inc.

TMDX ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $488.9M $337.2M $394.8M $201.2M $25.6M $24.6M $20.1M $20.2M
Accounts Receivable $84.3M $97.7M $63.6M $27.6M $5.9M $6.9M $6.6M $3.4M
Inventory $48.9M $46.6M $44.2M $20.6M $14.9M $11.9M $11.2M $9.3M
Total Current Assets $637.8M $497.2M $510.7M $252.3M $118.7M $146.8M $100.0M $34.8M
Property, Plant & Equipment $327.7M $286.0M $173.9M $19.2M $9.8M $4.8M $4.8M $3.5M
Goodwill $11.5M $11.5M $12.0M — — — — —
Intangible Assets (Excl. Goodwill) $1.9M $2.2M $2.4M — — — — —
Total Assets $1.07B $804.1M $706.0M $277.1M $134.9M $152.0M $105.3M $42.2M
Liabilities
Accounts Payable $10.4M $10.3M $12.7M $3.3M $6.7M $1.2M $7.2M $4.7M
Total Current Liabilities $89.3M $59.9M $54.9M $23.7M $23.2M $11.9M $16.1M $12.6M
Long-Term Debt — — — $58.7M $35.2M $34.7M $34.1M $33.7M
Total Liabilities $595.3M $575.5M $568.8M $89.8M $67.0M $48.1M $50.7M $47.9M
Stockholders' Equity
Retained Earnings $-278.0M $-468.2M $-503.7M $-478.7M $-442.4M $-398.2M $-369.5M $-335.9M
Total Stockholders' Equity $473.1M $228.6M $137.2M $187.4M $67.9M $103.9M $54.6M $-192.2M